Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07040501 · ClinicalTrials.gov registry record · NA
Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI
A NA study, sponsored by Case Comprehensive Cancer Center.
- Not yet
- Registry status
- NA
- Development phase
- 50
- Enrollment target
NCT07040501 is a NA study that has not yet begun recruiting, run by Case Comprehensive Cancer Center. The registered enrollment target is 50 participants.
The verdict
NCT07040501, a NA study, has not yet begun recruiting, sponsored by Case Comprehensive Cancer Center.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
Interventions
- DEVICE Chat GPT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-06 |
| Est. Completion | 2027-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07040501
The ClinicalTrials.gov registry entry for NCT07040501 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Case Comprehensive Cancer Center, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Chat GPT is the first listed.
NCT07040501 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07040501 about?
NCT07040501 is a clinical study titled "Improving Patient Understanding of Their Prostate Cancer Diagnosis Using AI". The purpose of this study is to determine if ChatGPT (an artificial intelligence driven chatbot) can help patients better understand their own pathology results and prostate cancer diagnosis.
What is the current status of trial NCT07040501?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-06. Estimated completion is 2027-01.
What interventions are being tested in trial NCT07040501?
The interventions under investigation include: Chat GPT (DEVICE).
Who is sponsoring clinical trial NCT07040501?
This trial is sponsored by Case Comprehensive Cancer Center, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.